Aluminum Induced Immunoexcitotoxicity in Neurodevelopmental and Neurodegenerative Disorders

A great deal has been learned about the neurotoxicity of aluminum over the past two decades in terms of its ability to disrupt cellular function. Newer evidence suggests that a more central pathophysiological mechanism may be re- sponsible for much of the toxicity of aluminum and aluminofluoride compounds on the brain. This mechanism involves activation of the brain's innate immune system, primarily the microglia, with a release of neurotoxic concentrations of ex- citotoxins and pro-inflammatory cytokines, chemokines and immune mediators. A large number of studies suggest that excitotoxicity plays a significant role in the neurotoxic action of a number of metals, including aluminum. Recently, re- searchers have found that while most of the chronic neurodegenerative effects of these metals are secondary to prolonged inflammation, it is the enhancement of excitotoxicity by the immune mediators that is responsible for most of the metal's toxicity. This enhancement occurs via a crosstalk between cytokine receptors and glutamate receptors. The author coined the name immunoexcitotoxicity to describe this process. This paper reviews the evidence linking immunoexcitotoxicity to aluminum's neurotoxic effects.

[1]  P. Brugières,et al.  Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. , 2009, Journal of inorganic biochemistry.

[2]  A. Suzumura,et al.  Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors. , 2008, Life sciences.

[3]  Raghubir P. Sharma,et al.  Modulation of tumor necrosis factor α expression in mouse brain after exposure to aluminum in drinking water , 1999, Archives of Toxicology.

[4]  T. Burbacher,et al.  Changes in the number of astrocytes and microglia in the thalamus of the monkey Macaca fascicularis following long-term subclinical methylmercury exposure. , 1996, Neurotoxicology.

[5]  J. Poderoso The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. , 2009, Archives of biochemistry and biophysics.

[6]  Shunqing Xu,et al.  Glia activation induced by peripheral administration of aluminum oxide nanoparticles in rat brains. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[7]  A. Suzumura [Neurotoxicity by microglia: the mechanisms and potential therapeutic strategy]. , 2009, Fukuoka igaku zasshi = Hukuoka acta medica.

[8]  P. Rakic,et al.  Modulation of neuronal migration by NMDA receptors. , 1993, Science.

[9]  Min-Xia Wang,et al.  APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. , 2009, Journal of inorganic biochemistry.

[10]  Vijay Kumar,et al.  Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminium , 2008, Brain Research.

[11]  T. Town,et al.  Journal of Neuroinflammation BioMed Central Review Involvement of β-chemokines in the development of inflammatory demyelination , 2005 .

[12]  M. Block,et al.  Chronic microglial activation and progressive dopaminergic neurotoxicity. , 2007, Biochemical Society transactions.

[13]  J. V. van Noort,et al.  Toll-like receptors in the CNS: implications for neurodegeneration and repair. , 2009, Progress in brain research.

[14]  M. Neutra,et al.  Peptomer aluminum oxide nanoparticle conjugates as systemic and mucosal vaccine candidates: synthesis and characterization of a conjugate derived from the C4 domain of HIV-1MN gp120. , 1997, Bioconjugate chemistry.

[15]  C. Ramassamy,et al.  Potential role of acrolein in neurodegeneration and in Alzheimer's disease. , 2010, Current molecular pharmacology.

[16]  J. Klinowski,et al.  Oxidative damage in Alzheimer's dementia, and the potential etiopathogenic role of aluminosilicates, microglia and micronutrient interactions. , 1992, EXS.

[17]  J. Walton An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. , 2007, Journal of inorganic biochemistry.

[18]  R. Rappuoli,et al.  Molecular and cellular signatures of human vaccine adjuvants , 2008, Proceedings of the National Academy of Sciences.

[19]  K. Schlett Glutamate as a modulator of embryonic and adult neurogenesis. , 2006, Current topics in medicinal chemistry.

[20]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[21]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[22]  N. Rothwell,et al.  The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. , 1997, The Journal of clinical investigation.

[23]  P. Gonçalves,et al.  The inhibitory effect of aluminium on the (Na+/K+)ATPase activity of rat brain cortex synaptosomes. , 2003, Journal of inorganic biochemistry.

[24]  P. Mander,et al.  Journal of Neuroinflammation Activation of Microglial Nadph Oxidase Is Synergistic with Glial Inos Expression in Inducing Neuronal Death: a Dual-key Mechanism of Inflammatory Neurodegeneration , 2005 .

[25]  G. Barrionuevo,et al.  mGluRs Modulate Strength and Timing of Excitatory Transmission in Hippocampal Area CA3 , 2011, Molecular Neurobiology.

[26]  T. Shirabe,et al.  Autopsy case of aluminum encephalopathy , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[27]  Christopher Exley,et al.  The immunobiology of aluminium adjuvants: how do they really work? , 2010, Trends in immunology.

[28]  Colm Cunningham,et al.  The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.

[29]  V. Perry,et al.  Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain , 1990, Neuroscience.

[30]  T. Koyama,et al.  Functional coupling between metabotropic glutamate receptors and G proteins in rat brain membranes. , 1996, European journal of pharmacology.

[31]  K. Murakami,et al.  Aluminum decreases the glutathione regeneration by the inhibition of NADP‐isocitrate dehydrogenase in mitochondria , 2004, Journal of cellular biochemistry.

[32]  B. Rosen,et al.  1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism , 1992, Journal of neurochemistry.

[33]  R. Agrawal,et al.  Inhibitory role of cholinergic system mediated via α7 nicotinic acetylcholine receptor in LPS-induced neuro-inflammation , 2010, Innate immunity.

[34]  C. Malbon,et al.  Physiological regulation of G protein-linked signaling. , 1999, Physiological reviews.

[35]  Z. Henderson,et al.  Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence , 2001, Brain Research Bulletin.

[36]  S. A. El-Rahman Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). , 2003, Pharmacological research.

[37]  J. Walton,et al.  Aluminum in hippocampal neurons from humans with Alzheimer's disease. , 2006, Neurotoxicology.

[38]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[39]  L. Barrier,et al.  Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes , 2006, Neurochemistry International.

[40]  Takashi Mori,et al.  Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 2007, Brain Research.

[41]  G. J. Harry,et al.  Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. , 2008, Expert opinion on drug metabolism & toxicology.

[42]  O. Strunecký,et al.  Fluoride plus aluminum: useful tools in laboratory investigations, but messengers of false information. , 2002, Physiological research.

[43]  V. Perry,et al.  Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease , 2009, Biological Psychiatry.

[44]  S. Bondy The neurotoxicity of environmental aluminum is still an issue. , 2010, Neurotoxicology.

[45]  J. Cui,et al.  Molecular Shuttle Chelation: The Use of Ascorbate, Desferrioxamine and Feralex-G in Combination to Remove Nuclear Bound Aluminum , 2004, Cellular and Molecular Neurobiology.

[46]  Guy C. Brown,et al.  Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons , 2010, Molecular Neurobiology.

[47]  C. Exley A molecular mechanism of aluminium-induced Alzheimer's disease? , 1999, Journal of inorganic biochemistry.

[48]  C. Shaw,et al.  Aluminum vaccine adjuvants: are they safe? , 2011, Current medicinal chemistry.

[49]  C. Exley,et al.  Aluminium in the human brain , 2011 .

[50]  S. Meshitsuka,et al.  Some aspects of astroglial functions and aluminum implications for neurodegeneration , 2006, Brain Research Reviews.

[51]  Florianne Monnet-Tschudi,et al.  Involvement of Environmental Mercury and Lead in the Etiology of Neurodegenerative Diseases , 2006, Reviews on environmental health.

[52]  K. Gulya,et al.  Cholinotoxic Effects of Aluminum in Rat Brain , 1990, Journal of neurochemistry.

[53]  O. Guillard,et al.  Modification of the blood-brain barrier through chronic intoxication by aluminum glutamate , 2007, Biological Trace Element Research.

[54]  V. Perry The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease , 2004, Brain, Behavior, and Immunity.

[55]  A. Zimmerman,et al.  Immunity, neuroglia and neuroinflammation in autism , 2005, International review of psychiatry.

[56]  M. Riepe,et al.  Excitotoxicity, energy metabolism and neurodegeneration , 1993, Journal of Inherited Metabolic Disease.

[57]  A. McAllister,et al.  Novel Roles for Immune Molecules in Neural Development: Implications for Neurodevelopmental Disorders , 2010, Front. Syn. Neurosci..

[58]  Sharon Moalem,et al.  Aluminum and Alzheimer's disease, a personal perspective after 25 years. , 2006, Journal of Alzheimer's disease : JAD.

[59]  R. Blaylock A possible central mechanism in autism spectrum disorders, part 2: immunoexcitotoxicity. , 2009, Alternative therapies in health and medicine.

[60]  Masahiko Watanabe,et al.  Indispensability of the glutamate transporters GLAST and GLT1 to brain development , 2006, Proceedings of the National Academy of Sciences.

[61]  Tomás R. Guilarte,et al.  Manganese Neurotoxicity: Lessons Learned from Longitudinal Studies in Nonhuman Primates , 2008, Environmental health perspectives.

[62]  M. Lanhers,et al.  Bioavailability and intestinal absorption of aluminum in rats , 2000, Biological Trace Element Research.

[63]  A. Chatterjee,et al.  Effects of aluminium exposure on brain glutamate and GABA systems: an experimental study in rats. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[64]  Y. Izumi,et al.  Neuroprotective effects of pyruvate following NMDA-mediated excitotoxic insults in hippocampal slices , 2010, Neuroscience Letters.

[65]  C. Theiss,et al.  Aluminum impairs gap junctional intercellular communication between astroglial cells in vitro , 2002, Cell and Tissue Research.

[66]  V. Perry,et al.  Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.

[67]  D. Lahiri,et al.  Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain , 2004, Journal of neuroscience research.

[68]  A. Adogwa,et al.  The effects of ingested aluminium on brain cytochrome oxidase activity. , 2009, West Indian medical journal.

[69]  C. Exley The pro-oxidant activity of aluminum. , 2004, Free radical biology & medicine.

[70]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[71]  A. Novelli,et al.  Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death , 1999, Brain Research.

[72]  M. Suckow,et al.  In vivo absorption of aluminium-containing vaccine adjuvants using 26Al. , 1997, Vaccine.

[73]  Demao Chen,et al.  Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain , 2006, Journal of Neuroimmunology.

[74]  L. Tomljenovic,et al.  Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link? , 2011, Journal of Alzheimer's disease : JAD.

[75]  M. S. Petrik,et al.  Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. , 2009, Journal of inorganic biochemistry.

[76]  Raghubir P. Sharma,et al.  Aluminum disrupts the pro-inflammatory cytokine/neurotrophin balance in primary brain rotation-mediated aggregate cultures: possible role in neurodegeneration. , 2003, Neurotoxicology.

[77]  R. G. Das,et al.  Aluminium-adjuvanted vaccines transiently increase aluminium levels in murine brain tissue. , 1992, Pharmacology & toxicology.

[78]  F. LaFerla Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.

[79]  J. Greenamyre Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease: “Use it and lose it” , 1991, Neurobiology of Aging.

[80]  E. Griesmaier,et al.  Glutamate receptors — Prenatal insults, long-term consequences , 2012, Pharmacology Biochemistry and Behavior.

[81]  J. Maroon,et al.  Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy—A unifying hypothesis , 2011, Surgical neurology international.

[82]  D. Souza,et al.  Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes , 2007, Brain Research.

[83]  Philippa Marrack,et al.  Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific Immunity1 , 2009, The Journal of Immunology.